{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:28:49Z","timestamp":1792272529917,"version":"4.4.0"},"reference-count":97,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T00:00:00Z","timestamp":1609200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-103955RB-100"],"award-info":[{"award-number":["PID2019-103955RB-100"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Hepatitis C virus (HCV) is an important human pathogen with a high chronicity rate. An estimated 71 million people worldwide are living with chronic hepatitis C (CHC) infection, which carries the risk of progression to hepatic fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Similar to other RNA viruses, HCV has a high rate of genetic variability generated by its high mutation rate and the actions of evolutionary forces over time. There are two levels of HCV genetic variability: intra-host variability, characterized by the distribution of HCV mutant genomes present in an infected individual, and inter-host variability, represented by the globally circulating viruses that give rise to different HCV genotypes and subtypes. HCV genetic diversity has important implications for virus persistence, pathogenesis, immune responses, transmission, and the development of successful vaccines and antiviral strategies. Here we will discuss how HCV genetic heterogeneity impacts viral spread and therapeutic control.<\/jats:p>","DOI":"10.3390\/v13010041","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T19:55:25Z","timestamp":1609271725000},"page":"41","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Therapy Implications of Hepatitis C Virus Genetic Diversity"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-4950","authenticated-orcid":false,"given":"Miguel Angel","family":"Martinez","sequence":"first","affiliation":[{"name":"Miguel Angel Mart\u00ednez, IrsiCaixa, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4126-2202","authenticated-orcid":false,"given":"Sandra","family":"Franco","sequence":"additional","affiliation":[{"name":"Miguel Angel Mart\u00ednez, IrsiCaixa, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1099\/vir.0.80401-0","article-title":"Genetic diversity and evolution of hepatitis C virus\u201415 years on","volume":"85","author":"Simmonds","year":"2004","journal-title":"J. Gen. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1073\/pnas.1101794108","article-title":"Characterization of a canine homolog of hepatitis C virus","volume":"108","author":"Kapoor","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1128\/JVI.00250-12","article-title":"Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host","volume":"86","author":"Burbelo","year":"2012","journal-title":"J. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM197504102921502","article-title":"Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B","volume":"292","author":"Feinstone","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.277.5325.570","article-title":"Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA","volume":"277","author":"Kolykhalov","year":"1997","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.2496467","article-title":"An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis","volume":"244","author":"Kuo","year":"1989","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/hep.27163","article-title":"Genetics of spontaneous clearance of hepatitis C virus infection: A complex topic with much to learn","volume":"60","author":"Grebely","year":"2014","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_10","unstructured":"World Health Organization (2017, March 10). Global Hepatitis Report 2017. Available online: http:\/\/apps.who.int\/iris\/bitstream\/10665\/255016\/1\/9789241565455-eng.pdf?ua=1."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1073\/pnas.1307527110","article-title":"Ultrastructural analysis of hepatitis C virus particles","volume":"110","author":"Catanese","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","first-page":"113","article-title":"Hepatitis C Virus Proteins: From Structure to Function","volume":"Volume 369","author":"Moradpour","year":"2013","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"a037093","DOI":"10.1101\/cshperspect.a037093","article-title":"Hepatitis C virus replication","volume":"10","author":"Tabata","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jmb.2010.02.005","article-title":"Unfinished stories on viral quasispecies and darwinian views of evolution","volume":"397","author":"Cacho","year":"2010","journal-title":"J. Mol. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Domingo, E., and Perales, C. (2019). Viral quasispecies. PLoS Genet., 15.","DOI":"10.1371\/journal.pgen.1008271"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF00623322","article-title":"Selforganization of matter and the evolution of biological macromolecules","volume":"58","author":"Eigen","year":"1971","journal-title":"Naturwissenschaften"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.molcel.2020.07.027","article-title":"Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting","volume":"79","author":"Robson","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1073\/pnas.88.8.3392","article-title":"Nucleotide sequence and mutation rate of the H strain of hepatitis C virus","volume":"88","author":"Ogata","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/hep.21623","article-title":"Genetic and catalytic efficiency structure of an HCV protease quasispecies","volume":"45","author":"Franco","year":"2007","journal-title":"Hepatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1128\/JVI.01097-15","article-title":"Similarities between Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Genetic and Phenotypic Protease Quasispecies Diversity","volume":"89","author":"Martinez","year":"2015","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1128\/jvi.68.5.3425-3436.1994","article-title":"Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation","volume":"68","author":"Martell","year":"1994","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1128\/JVI.00201-09","article-title":"Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo","volume":"83","author":"Cuevas","year":"2009","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ribeiro, R.M., Li, H., Wang, S., Stoddard, M.B., Learn, G.H., Korber, B.T., Bhattacharya, T., Guedj, J., Parrish, E.H., and Hahn, B.H. (2012). Quantifying the Diversification of Hepatitis C Virus (HCV) during Primary Infection: Estimates of the In Vivo Mutation Rate. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002881"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/infdis\/jiy401","article-title":"Identification of a novel hepatitis C virus genotype from Punjab, India: Expanding classification of hepatitis C virus into 8 genotypes","volume":"218","author":"Borgia","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study","volume":"2","author":"Blach","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tim.2014.02.005","article-title":"Comparative analysis of the molecular mechanisms of recombination in hepatitis C virus","volume":"22","author":"Galli","year":"2014","journal-title":"Trends Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.288.5464.339","article-title":"The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies","volume":"288","author":"Farci","year":"2000","journal-title":"Science"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nmicrobiol.2016.45","article-title":"Highly heterogeneous mutation rates in the hepatitis C virus genome","volume":"1","author":"Geller","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Raghwani, J., Rose, R., Sheridan, I., Lemey, P., Suchard, M.A., Santantonio, T., Farci, P., Klenerman, P., and Pybus, O.G. (2016). Exceptional Heterogeneity in Viral Evolutionary Dynamics Characterises Chronic Hepatitis C Virus Infection. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005894"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2013.0168","DOI":"10.1098\/rstb.2013.0168","article-title":"Evolutionary analysis of hepatitis C virus gene sequences from 1953","volume":"368","author":"Gray","year":"2013","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"14562","DOI":"10.1073\/pnas.1210592109","article-title":"Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis","volume":"109","author":"Farci","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"0282","DOI":"10.1371\/journal.pcbi.0030029","article-title":"Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics","volume":"3","author":"Lemey","year":"2007","journal-title":"PLoS Comput. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1002\/cld.882","article-title":"Reflections on the History of HCV: A Posthumous Examination","volume":"15","author":"Alter","year":"2020","journal-title":"Clin. Liver Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1084\/jem.20090766","article-title":"Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation","volume":"207","author":"Fofana","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1073\/pnas.1516879113","article-title":"Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue","volume":"113","author":"Harouaka","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/j.1600-6143.2009.02666.x","article-title":"Hepatitis C Virus Compartmentalization and Infection Recurrence after Liver Transplantation","volume":"9","author":"Ramirez","year":"2009","journal-title":"Am. J. Transplant."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jhep.2016.07.048","article-title":"High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease","volume":"66","author":"Hedegaard","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Li, H., Stoddard, M.B., Wang, S., Blair, L.M., Giorgi, E.E., Parrish, E.H., Learn, G.H., Hraber, P., Goepfert, P.A., and Saag, M.S. (2012). Elucidation of Hepatitis C Virus Transmission and Early Diversification by Single Genome Sequencing. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002880"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/JVI.02156-15","article-title":"Single-Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification","volume":"90","author":"Li","year":"2016","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.meegid.2019.02.032","article-title":"Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing","volume":"71","author":"Abayasingam","year":"2019","journal-title":"Infect. Genet. Evol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/jvh.13051","article-title":"Genomic variability of within-host hepatitis C variants in acute infection","volume":"26","author":"Rodrigo","year":"2019","journal-title":"J. Viral Hepat."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jhep.2016.07.035","article-title":"The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control","volume":"65","author":"Bukh","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coviro.2020.10.002","article-title":"Immune system control of hepatitis C virus infection","volume":"46","author":"Stuart","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.1279801","article-title":"Lack of protective immunity against reinfection with hepatitis C virus","volume":"258","author":"Farci","year":"1992","journal-title":"Science"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1053\/jhep.2001.24371","article-title":"Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection","volume":"33","author":"Bassett","year":"2001","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/j.gastro.2014.05.010","article-title":"Detection of a sexually transmitted hepatitis C virus protease inhibitor-resistance variant in a human immunodeficiency virus-infected homosexual man","volume":"147","author":"Franco","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/hep.30699","article-title":"Interferon-Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection","volume":"70","author":"Wrensch","year":"2019","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.20749","article-title":"Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C","volume":"42","author":"Cox","year":"2005","journal-title":"Hepatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/hep.22242","article-title":"Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection","volume":"47","author":"Timm","year":"2008","journal-title":"Hepatology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/hep.21049","article-title":"Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution","volume":"43","author":"McKiernan","year":"2006","journal-title":"Hepatology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/gut.2010.228403","article-title":"Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection","volume":"60","author":"Fitzmaurice","year":"2011","journal-title":"Gut"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jhep.2020.09.022","article-title":"T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine","volume":"74","author":"Thimme","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jhep.2018.10.011","article-title":"Clinical Practice Guidelines of the European Association for the study of the Liver \u2013 Advancing methodology but preserving practicability","volume":"70","author":"Cornberg","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.antiviral.2017.02.014","article-title":"Current therapy for chronic hepatitis C: The role of direct-acting antivirals","volume":"142","author":"Li","year":"2017","journal-title":"Antiviral Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.3748\/wjg.v20.i29.9633","article-title":"Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy","volume":"20","author":"Ansaldi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","article-title":"Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection","volume":"364","author":"Jacobson","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for Untreated Chronic HCV Genotype 1 Infection","volume":"364","author":"Poordad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0140-6736(14)60538-9","article-title":"Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"384","author":"Manns","year":"2014","journal-title":"Lancet"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1214854","article-title":"Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options","volume":"368","author":"Jacobson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa1402355","article-title":"Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis","volume":"370","author":"Kowdley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMoa1316366","article-title":"Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(14)61036-9","article-title":"Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: The COSMOS randomised study","volume":"384","author":"Lawitz","year":"2014","journal-title":"Lancet"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa1402869","article-title":"ABT-450\/r\u2013Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis","volume":"370","author":"Poordad","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJMoa1315722","article-title":"Treatment of HCV with ABT-450\/r\u2013Ombitasvir and Dasabuvir with Ribavirin","volume":"370","author":"Feld","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-8976-8_1","article-title":"Overview of direct-acting antiviral drugs and drug resistance of hepatitis C virus","volume":"Volume 1911","author":"Li","year":"2019","journal-title":"Methods in Molecular Biology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"a036913","DOI":"10.1101\/cshperspect.a036913","article-title":"Hepatitis c virus epidemiology and the impact of interferon-free hepatitis c virus therapy","volume":"10","author":"Lazarus","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"10380","DOI":"10.1021\/acs.jmedchem.0c00935","article-title":"Synthesis and Anti-HCV Activity of Sugar-Modified Guanosine Analogues: Discovery of AL-611 as an HCV NS5B Polymerase Inhibitor for the Treatment of Chronic Hepatitis C","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1021\/acs.jmedchem.9b00143","article-title":"Synthesis and Anti-HCV Activities of 4\u2032-Fluoro-2\u2032-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4\u2032-Fluoro-2\u2032-C-methyluridine 5\u2032-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection","volume":"62","author":"Wang","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1021\/acs.jmedchem.8b01719","article-title":"Design of N-Benzoxaborole Benzofuran GSK8175\u2014Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor","volume":"62","author":"Chong","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1021\/acs.jmedchem.9b00415","article-title":"Resurrecting the Condemned: Identification of N-Benzoxaborole Benzofuran GSK8175 as a Clinical Candidate with Reduced Metabolic Liability","volume":"62","author":"Zhan","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"10563","DOI":"10.1021\/acs.jmedchem.9b01562","article-title":"Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical Candidate","volume":"62","author":"Ramdas","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1021\/acs.jmedchem.0c00082","article-title":"Discovery of a Silicon-Containing Pan-Genotype Hepatitis C Virus NS5A Inhibitor","volume":"63","author":"Liu","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1021\/acs.jmedchem.9b02176","article-title":"GSK2818713, a Novel Biphenylene Scaffold-Based Hepatitis C NS5A Replication Complex Inhibitor with Broad Genotype Coverage","volume":"63","author":"Kazmierski","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1021\/acs.jmedchem.0c00232","article-title":"2-((4-Arylpiperazin-1-yl)methyl)benzonitrile Derivatives as Orally Available Inhibitors of Hepatitis C Virus with a Novel Mechanism of Action","volume":"63","author":"Jiang","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"105562","DOI":"10.1016\/j.ijantimicag.2018.10.005","article-title":"Quasispecies dynamics and clinical significance of hepatitis C virus (HCV) antiviral resistance","volume":"56","author":"Perales","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2017.11.007","article-title":"Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals","volume":"154","author":"Dietz","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2015.09.011","article-title":"The importance of resistance to direct antiviral drugs in HCV infection in clinical practice","volume":"64","author":"Sarrazin","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jhep.2019.07.025","article-title":"Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C","volume":"71","author":"Childs","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1053\/j.gastro.2017.12.015","article-title":"Efficacy of NS5A Inhibitors Against Hepatitis C Virus Genotypes 1\u20137 and Escape Variants","volume":"154","author":"Gottwein","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkz415","article-title":"SRNAbench and sRNAtoolbox 2019: Intuitive fast small RNA profiling and differential expression","volume":"47","author":"Rueda","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/j.gastro.2012.02.027","article-title":"New virologic tools for management of chronic hepatitis B and C","volume":"142","author":"Chevaliez","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.30647","article-title":"Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants","volume":"70","author":"Jensen","year":"2019","journal-title":"Hepatology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMoa1613512","article-title":"Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection","volume":"376","author":"Gordon","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/hep.29671","article-title":"Glecaprevir\/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure","volume":"67","author":"Poordad","year":"2018","journal-title":"Hepatology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2020.05.029","article-title":"Efficacy of NS5A inhibitors against unusual and potentially difficult-to-treat HCV subtypes commonly found in sub-Saharan Africa and South East Asia","volume":"73","author":"Nguyen","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/jvh.13022","article-title":"Liver transplant listing for hepatitis C-associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct-acting antiviral therapy","volume":"26","author":"Vaziri","year":"2019","journal-title":"J. Viral Hepat."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","article-title":"Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: A prospective cohort study","volume":"393","author":"Carrat","year":"2019","journal-title":"Lancet"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1055\/s-0039-1687823","article-title":"Retreatment of Hepatitis C Virus-Infected Patients with Direct-Acting Antiviral Failures","volume":"39","author":"Pawlotsky","year":"2019","journal-title":"Semin. Liver Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/1\/41\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:47:34Z","timestamp":1760179654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/1\/41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,29]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["v13010041"],"URL":"https:\/\/doi.org\/10.3390\/v13010041","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,29]]}}}